Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/07/04 15:18
2015/07/04 15:18
6h
FOSTER CITY, Californië--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) kondigde vandaag aan dat het Japans Ministerie van Gezondheid, Arbeid en Welzijn (MHLW, Japanese Ministry of Health,...
2015/07/04 15:18
2015/07/04 15:18
Latest videos
2015/07/04 15:18
2015/07/04 15:18
6h
FOSTER CITY, California--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) ha anunciado hoy que el Ministerio de Sanidad, Trabajo y Bienestar japonés ha aprobado Harvoni® (ledipasvir 90...
2015/07/04 15:18
2015/07/04 15:18
6h
FOSTER CITY, Kalifornien (USA)--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc. (NASDAQ: GILD) hat heute bekannt gegeben, dass das japanische Ministerium für Gesundheit, Arbeit und Soziales...
2015/07/04 12:19
2015/07/04 12:19
9h
FOSTER CITY, California--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) ha annunciato oggi che il Ministero della salute, del lavoro e del welfare del Giappone (Ministry of Health, Labour and...
2015/07/04 12:19
2015/07/04 12:19
9h
FOSTER CITY, Californie--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ : GILD) a annoncé aujourd'hui que le Ministère de la santé, du travail et du bien-être (MSTB) du Japon avait autorisé Harvoni®...
2015/07/03 06:17
2015/07/03 06:17
1d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Harvoni® (ledipasvir 90...
2015/07/02 14:14
2015/07/02 14:14
2d
... -- Here's an in-depth look at the life of Donald Rumsfeld, former U.S. Secretary of Defense Personal: Birth date: July 9, 1932 Birth place: Chicago, Illinois Birth name: Donald Harold...
2015/07/01 15:23
2015/07/01 15:23
3d
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. "We...
2015/06/29 23:22
2015/06/29 23:22
4d
NEW YORK (TheStreet) -- Gilead Sciences(GILD - Get Report) shares are down 2.6% to $116.40 in afternoon trading on Monday after the Food and Drug Administration was sued by two health groups looking...
2015/06/26 13:52
2015/06/26 13:52
8d
The increasingly conventional guidelines for Truvada say that it should be part of a broad safer-sex tool kit along with other prevention methods. Researchers also are investigating a long-acting...
2015/06/23 02:06
2015/06/23 02:06
11d
Greg Jefferys, of Woodbridge, has Hepatitis C and has travelled to India to obtain drugs he needs for treatment which are highly expensive in Australia. Picture NIKKI DAVIS-JONES IT’S the...
Read more at Perth Now, MedCity News
2015/06/19 21:27
2015/06/19 21:27
15d
While the stocks are not cheap, they're not expensive, he added. What investors are paying for is high quality growth and high quality earnings. In fact, he thinks people have underappreciated...
2015/06/19 16:49
2015/06/19 16:49
15d
China’s government has rejected Gilead Sciences Inc.’s patent application for its controversial hepatitis C drug Sovaldi, but whether that really strikes a blow to the company’s plans is up for...
2015/06/19 15:22
2015/06/19 15:22
15d
Sovaldi has received criticism due to its prohibitive costs. Priced at $1,000 a pill, the complete 12-week treatment course in the U.S. costs $84,000. Despite the regulatory rejection, Gilead does...
2015/06/12 15:22
2015/06/12 15:22
22d
GILD's very impressive revenue growth greatly exceeded the industry average of 21.6%. Since the same quarter one year prior, revenues leaped by 51.9%. Growth in the company's revenue appears to have...
2015/06/08 21:17
2015/06/08 21:17
26d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from two upcoming investor conferences: the Goldman Sachs 36th...
2015/07/04 15:18
2015/07/04 15:18
Latest from Twitter